ArriVent BioPharma (AVBP)
Nasdaq • AVBP • US04272N1028
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 23.4% of free float sold short, 2.7 days to cover, cost to borrow 0.73%. Sign up for live short interest data.
Market Cap
698m USD | # 5539 in US
Volume
1.28m shares | 30.59m USD
Shares Outstanding
49.31m
Free Float Shares
60.01% | 29.59m
